“Funding that is focused on the ability to diagnose diseases precisely will just have inestimable value because that's the gate through which precision medicine has to go. Unless you can diagnose the disease precisely, care has to remain in the hands of expensive institutions and expensive caregivers.”

American business scholar and professor, Christensen is best known for developing the theory of disruptive innovation, which explains how established companies often fail to recognize emerging markets that eventually overtake them. His work reshaped strategic thinking in corporate leadership and entrepreneurship.